Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia.

Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Progress in Neuro-Psychopharmacology and Biological Psychiatry Pubmed

Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia.

Zavitsanou, Katerina; Garrick, Therese; Huang, Xu Feng
Progress in Neuro-Psychopharmacology and Biological Psychiatry , Volume 28 (2): 6 – May 28, 2004
Download PDF

Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia.

Zavitsanou, Katerina; Garrick, Therese; Huang, Xu Feng
Progress in Neuro-Psychopharmacology and Biological Psychiatry , Volume 28 (2): 6 – May 28, 2004

Loading next page...
 
/lp/pubmed/selective-antagonist-3h-sr141716a-binding-to-cannabinoid-cb1-receptors-bfzTMgyeby

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0278-5846
DOI
10.1016/j.pnpbp.2003.11.005
pmid
14751433

Abstract

Journal

Progress in Neuro-Psychopharmacology and Biological Psychiatry – Pubmed

Published: May 28, 2004

There are no references for this article.